Home6541 • TPE
add
Tanvex Biopharma Inc
Previous close
$68.20
Day range
$68.10 - $70.00
Year range
$35.05 - $80.00
Market cap
11.40B TWD
Avg Volume
242.84K
P/E ratio
-
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
| (TWD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 17.01M | -0.43% |
Operating expense | 362.53M | -29.21% |
Net income | -366.72M | 27.46% |
Net profit margin | -2.16K | 27.15% |
Earnings per share | — | — |
EBITDA | -337.30M | 28.02% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
| (TWD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.04B | -14.70% |
Total assets | 3.39B | -9.46% |
Total liabilities | 1.91B | -2.10% |
Total equity | 1.48B | — |
Shares outstanding | 164.03M | — |
Price to book | 7.57 | — |
Return on assets | -29.49% | — |
Return on capital | -31.54% | — |
Cash Flow
Net change in cash
| (TWD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -366.72M | 27.46% |
Cash from operations | -339.49M | 13.68% |
Cash from investing | -159.26M | -2,366.78% |
Cash from financing | 1.02B | -12.81% |
Net change in cash | 525.09M | -33.81% |
Free cash flow | -250.23M | -12.86% |
About
Founded
2013
Website
Employees
149
